X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-06-22 | CBIO | Lynch Ryan | See Remarks | S - Sale | $17.99 | -465 | 13,871 | -3% | -$8,365 | ||||||
2026-06-22 | CBIO | Pinkas Jan | Chief Scientific Officer | S - Sale | $17.99 | -1,288 | 22,239 | -5% | -$23,171 | ||||||
2026-06-22 | CBIO | Scalzo Richard William | CFO | S - Sale | $17.99 | -1,112 | 20,298 | -5% | -$20,005 | ||||||
2026-06-22 | CBIO | Bispham Barbara Harlin | See Remarks | S - Sale | $17.99 | -1,218 | 19,330 | -6% | -$21,912 | ||||||
2026-06-22 | CBIO | Im Ellie Eunkyung | Chief Medical Officer | S - Sale | $17.99 | -1,219 | 22,069 | -5% | -$21,930 | ||||||
2026-06-22 | CBIO | McNeill Jonathan | Pres, COO | S - Sale | $17.99 | -20,549 | 139,158 | -13% | -$369,677 | ||||||
2026-06-22 | CBIO | Brumm Joshua T | CEO | S - Sale | $17.99 | -42,305 | 281,212 | -13% | -$761,067 | ||||||
| D | 2025-12-04 | CBIO | Fairmount Funds Management LLC | Dir, 10% | P - Purchase | $13.41 | +1,360,000 | 2,747,866 | +98% | +$18,237,600 | |||||
| M | 2024-08-07 | GLYC | Invus Public Equities, L.P. | 10% | S - Sale | $0.19 | -322,361 | 6,317,565 | -5% | -$61,206 | |||||
| M | 2024-08-05 | GLYC | Invus Public Equities, L.P. | 10% | S - Sale | $0.19 | -220,255 | 6,639,926 | -3% | -$41,184 | |||||
| M | 2024-08-01 | GLYC | Invus Public Equities, L.P. | 10% | S - Sale | $0.20 | -349,764 | 6,860,181 | -5% | -$71,097 | |||||
| M | 2024-07-26 | GLYC | Invus Public Equities, L.P. | 10% | S - Sale | $0.23 | -1,379,119 | 7,209,945 | -16% | -$315,262 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |